The Cross-sectional and longitudinal associations between il-6, il-10, and TNFα and cognitive outcomes in the mayo clinic study of aging

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Chronic inflammation has been linked with geriatric-related conditions, including dementia. Inflammatory cytokine levels, including interleukin (IL)-6, IL-10, and tumor necrosis factor (TNF) α, in the blood have been associated with cognitive impairment and decline. However, evidence has been mixed. Methods: We examined the cross-sectional and longitudinal associations between baseline-measured IL-6, IL-10, and TNFα levels and the ratio of IL-6/IL-10 with cognitive test performance and mild cognitive impairment (MCI) among 1,602 community-dwelling older adults (median age = 72.8) enrolled in the Mayo Clinic Study of Aging. Approximately half (46.5%) of participants were female and 98.6% were white. At baseline and follow-up visits (occurring at 15-month intervals), participants completed neuropsychological testing, blood draws, and had a clinical consensus diagnosis. Results: In multivariable cross-sectional analyses, we did not observe an association between inflammatory cytokine levels and global or domain-specific cognitive z scores; however, higher IL-6 and IL-10 levels were associated with greater odds of a MCI diagnosis. Longitudinally, we did not observe any association between inflammatory cytokine levels and cognitive test performance or risk of MCI. Sex, age, cognitive status, APOE ϵ4 genotype, diabetes, depression, and cerebral amyloid-beta deposition were not effect modifiers. Conclusions: These results suggest that plasma inflammatory markers may not be useful to ascertain risk for cognitive decline and MCI in the general population.

Original languageEnglish (US)
Article numbergly217
Pages (from-to)1289-1295
Number of pages7
JournalJournals of Gerontology - Series A Biological Sciences and Medical Sciences
Volume74
Issue number8
DOIs
StatePublished - Jul 12 2019

Fingerprint

Tumor Necrosis Factor-alpha
Interleukin-10
Interleukin-6
Cytokines
Independent Living
Cognitive Dysfunction
Amyloid
Geriatrics
Dementia
Cross-Sectional Studies
Genotype
Depression
Inflammation
Population

Keywords

  • Epidemiology
  • Inflammation
  • Mild cognitive impairment

ASJC Scopus subject areas

  • Aging
  • Geriatrics and Gerontology

Cite this

@article{99faf5aa7dd6495aae9a4bee954c9497,
title = "The Cross-sectional and longitudinal associations between il-6, il-10, and TNFα and cognitive outcomes in the mayo clinic study of aging",
abstract = "Background: Chronic inflammation has been linked with geriatric-related conditions, including dementia. Inflammatory cytokine levels, including interleukin (IL)-6, IL-10, and tumor necrosis factor (TNF) α, in the blood have been associated with cognitive impairment and decline. However, evidence has been mixed. Methods: We examined the cross-sectional and longitudinal associations between baseline-measured IL-6, IL-10, and TNFα levels and the ratio of IL-6/IL-10 with cognitive test performance and mild cognitive impairment (MCI) among 1,602 community-dwelling older adults (median age = 72.8) enrolled in the Mayo Clinic Study of Aging. Approximately half (46.5{\%}) of participants were female and 98.6{\%} were white. At baseline and follow-up visits (occurring at 15-month intervals), participants completed neuropsychological testing, blood draws, and had a clinical consensus diagnosis. Results: In multivariable cross-sectional analyses, we did not observe an association between inflammatory cytokine levels and global or domain-specific cognitive z scores; however, higher IL-6 and IL-10 levels were associated with greater odds of a MCI diagnosis. Longitudinally, we did not observe any association between inflammatory cytokine levels and cognitive test performance or risk of MCI. Sex, age, cognitive status, APOE ϵ4 genotype, diabetes, depression, and cerebral amyloid-beta deposition were not effect modifiers. Conclusions: These results suggest that plasma inflammatory markers may not be useful to ascertain risk for cognitive decline and MCI in the general population.",
keywords = "Epidemiology, Inflammation, Mild cognitive impairment",
author = "Wennberg, {Alexandra M.V.} and Hagen, {Clinton E.} and Machulda, {Mary Margaret} and Knopman, {David S} and Petersen, {Ronald Carl} and Mielke, {Michelle M}",
year = "2019",
month = "7",
day = "12",
doi = "10.1093/gerona/gly217",
language = "English (US)",
volume = "74",
pages = "1289--1295",
journal = "Journals of Gerontology - Series A Biological Sciences and Medical Sciences",
issn = "1079-5006",
publisher = "Oxford University Press",
number = "8",

}

TY - JOUR

T1 - The Cross-sectional and longitudinal associations between il-6, il-10, and TNFα and cognitive outcomes in the mayo clinic study of aging

AU - Wennberg, Alexandra M.V.

AU - Hagen, Clinton E.

AU - Machulda, Mary Margaret

AU - Knopman, David S

AU - Petersen, Ronald Carl

AU - Mielke, Michelle M

PY - 2019/7/12

Y1 - 2019/7/12

N2 - Background: Chronic inflammation has been linked with geriatric-related conditions, including dementia. Inflammatory cytokine levels, including interleukin (IL)-6, IL-10, and tumor necrosis factor (TNF) α, in the blood have been associated with cognitive impairment and decline. However, evidence has been mixed. Methods: We examined the cross-sectional and longitudinal associations between baseline-measured IL-6, IL-10, and TNFα levels and the ratio of IL-6/IL-10 with cognitive test performance and mild cognitive impairment (MCI) among 1,602 community-dwelling older adults (median age = 72.8) enrolled in the Mayo Clinic Study of Aging. Approximately half (46.5%) of participants were female and 98.6% were white. At baseline and follow-up visits (occurring at 15-month intervals), participants completed neuropsychological testing, blood draws, and had a clinical consensus diagnosis. Results: In multivariable cross-sectional analyses, we did not observe an association between inflammatory cytokine levels and global or domain-specific cognitive z scores; however, higher IL-6 and IL-10 levels were associated with greater odds of a MCI diagnosis. Longitudinally, we did not observe any association between inflammatory cytokine levels and cognitive test performance or risk of MCI. Sex, age, cognitive status, APOE ϵ4 genotype, diabetes, depression, and cerebral amyloid-beta deposition were not effect modifiers. Conclusions: These results suggest that plasma inflammatory markers may not be useful to ascertain risk for cognitive decline and MCI in the general population.

AB - Background: Chronic inflammation has been linked with geriatric-related conditions, including dementia. Inflammatory cytokine levels, including interleukin (IL)-6, IL-10, and tumor necrosis factor (TNF) α, in the blood have been associated with cognitive impairment and decline. However, evidence has been mixed. Methods: We examined the cross-sectional and longitudinal associations between baseline-measured IL-6, IL-10, and TNFα levels and the ratio of IL-6/IL-10 with cognitive test performance and mild cognitive impairment (MCI) among 1,602 community-dwelling older adults (median age = 72.8) enrolled in the Mayo Clinic Study of Aging. Approximately half (46.5%) of participants were female and 98.6% were white. At baseline and follow-up visits (occurring at 15-month intervals), participants completed neuropsychological testing, blood draws, and had a clinical consensus diagnosis. Results: In multivariable cross-sectional analyses, we did not observe an association between inflammatory cytokine levels and global or domain-specific cognitive z scores; however, higher IL-6 and IL-10 levels were associated with greater odds of a MCI diagnosis. Longitudinally, we did not observe any association between inflammatory cytokine levels and cognitive test performance or risk of MCI. Sex, age, cognitive status, APOE ϵ4 genotype, diabetes, depression, and cerebral amyloid-beta deposition were not effect modifiers. Conclusions: These results suggest that plasma inflammatory markers may not be useful to ascertain risk for cognitive decline and MCI in the general population.

KW - Epidemiology

KW - Inflammation

KW - Mild cognitive impairment

UR - http://www.scopus.com/inward/record.url?scp=85062955355&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062955355&partnerID=8YFLogxK

U2 - 10.1093/gerona/gly217

DO - 10.1093/gerona/gly217

M3 - Article

VL - 74

SP - 1289

EP - 1295

JO - Journals of Gerontology - Series A Biological Sciences and Medical Sciences

JF - Journals of Gerontology - Series A Biological Sciences and Medical Sciences

SN - 1079-5006

IS - 8

M1 - gly217

ER -